These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 27157372)

  • 1. Long-Term Oncologic Outcomes of Salvage Cryoablation for Radio-Recurrent Prostate Cancer.
    Siddiqui KM; Billia M; Al-Zahrani A; Williams A; Goodman C; Arifin A; Violette P; Bauman G; Chin JL
    J Urol; 2016 Oct; 196(4):1105-11. PubMed ID: 27157372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvage cryoablation of the prostate: followup and analysis of predictive factors for outcome.
    Ng CK; Moussa M; Downey DB; Chin JL
    J Urol; 2007 Oct; 178(4 Pt 1):1253-7; discussion 1257. PubMed ID: 17698104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-Year Biochemical Progression-Free Survival Following Salvage Whole-Gland Prostate Cryoablation: Defining Success with Nadir Prostate-Specific Antigen.
    Kovac E; ElShafei A; Tay KJ; Mendez M; Polascik TJ; Jones JS
    J Endourol; 2016 Jun; 30(6):624-31. PubMed ID: 26915721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage focal prostate cryoablation for locally recurrent prostate cancer after radiotherapy: initial results from the cryo on-line data registry.
    Li YH; Elshafei A; Agarwal G; Ruckle H; Powsang J; Jones JS
    Prostate; 2015 Jan; 75(1):1-7. PubMed ID: 25283814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy.
    de Castro Abreu AL; Bahn D; Leslie S; Shoji S; Silverman P; Desai MM; Gill IS; Ukimura O
    BJU Int; 2013 Aug; 112(3):298-307. PubMed ID: 23826840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.
    Hubosky SG; Fabrizio MD; Schellhammer PF; Barone BB; Tepera CM; Given RW
    J Endourol; 2007 Dec; 21(12):1521-31. PubMed ID: 18186694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage Cryoablation for Radiorecurrent Prostate Cancer: Initial Experience at a Regional Health Care System.
    Safavy S; Jabaji RB; Lu SM; Slezak JM; Cosmatos HA; Williams SG; Finley DS
    Perm J; 2019; 23():. PubMed ID: 31050644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological, Oncologic and Functional Outcomes of a Prospective Registry of Salvage High Intensity Focused Ultrasound Ablation for Radiorecurrent Prostate Cancer.
    Siddiqui KM; Billia M; Arifin A; Li F; Violette P; Chin JL
    J Urol; 2017 Jan; 197(1):97-102. PubMed ID: 27422297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-intensity Focused Ultrasound (HIFU) as salvage therapy for radio-recurrent prostate cancer: predictors of disease response.
    Dason S; Wong NC; Allard CB; Hoogenes J; Orovan W; Shayegan B
    Int Braz J Urol; 2018; 44(2):248-257. PubMed ID: 29211405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage Prostate Cryoablation for the Management of Local Recurrence After Primary Cryotherapy: A Retrospective Analysis of Functional and Intermediate-Term Oncological Outcomes Associated With a Second Therapeutic Freeze.
    Aminsharifi A; Jibara G; Tsivian E; Tsivian M; Elshafei A; Polascik TJ
    Clin Genitourin Cancer; 2019 Aug; 17(4):e831-e836. PubMed ID: 31213413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage Percutaneous Cryoablation for Locally Recurrent Renal-Cell Carcinoma After Primary Cryoablation.
    Okhunov Z; Chamberlin J; Moreira DM; George A; Babaian K; Shah P; Youssef R; Kaler KS; Lobko II; Kavoussi L; Landman J
    J Endourol; 2016 Jun; 30(6):632-7. PubMed ID: 27009377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease-free survival following salvage cryotherapy for biopsy-proven radio-recurrent prostate cancer.
    Williams AK; Martínez CH; Lu C; Ng CK; Pautler SE; Chin JL
    Eur Urol; 2011 Sep; 60(3):405-10. PubMed ID: 21185115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemigland Cryoablation of Localized Low, Intermediate and High Risk Prostate Cancer: Oncologic and Functional Outcomes at 5 Years.
    Oishi M; Gill IS; Tafuri A; Shakir A; Cacciamani GE; Iwata T; Iwata A; Ashrafi A; Park D; Cai J; Desai M; Ukimura O; Bahn DK; Abreu AL
    J Urol; 2019 Dec; 202(6):1188-1198. PubMed ID: 31347953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage prostate cryoablation: initial results from the cryo on-line data registry.
    Pisters LL; Rewcastle JC; Donnelly BJ; Lugnani FM; Katz AE; Jones JS
    J Urol; 2008 Aug; 180(2):559-63; discussion 563-4. PubMed ID: 18554664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of prostate-specific antigen biochemical recurrence in patients undergoing primary whole-gland prostate cryoablation.
    Liu YY; Chiang PH; Chuang YC; Lee WC; Cheng YT; Wang HJ
    Ann Surg Oncol; 2015 May; 22(5):1612-7. PubMed ID: 25287436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
    Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
    Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Outcomes of Whole Gland Salvage Cryotherapy for Locally Recurrent Prostate Cancer following Radiation Therapy: A Combined Analysis of Two Centers.
    Chin JL; Lavi A; Metcalfe MJ; Siddiqui K; Dewar M; Petros FG; Li R; Nogueras González GM; Wang X; Nair SM; Ward JF; Pisters L
    J Urol; 2021 Sep; 206(3):646-654. PubMed ID: 33908799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate Specific Antigen Nadir of 0.1 or Less Is a Predictor of Treatment Success in Men Undergoing Salvage Whole Prostate Gland Cryoablation.
    Nyame YA; Elshafei A; Greene DJ; Arora HC; Given RW; Tay KJ; Polascik TJ; Ross AE; Mouraviev VB; Lugnani F; Jones JS
    J Endourol; 2017 May; 31(5):497-501. PubMed ID: 28437170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous MR-guided focal cryoablation for recurrent prostate cancer following radiation therapy: retrospective analysis of iceball margins and outcomes.
    Overduin CG; Jenniskens SFM; Sedelaar JPM; Bomers JGR; Fütterer JJ
    Eur Radiol; 2017 Nov; 27(11):4828-4836. PubMed ID: 28409355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robotic Salvage Lymph Node Dissection in Recurrent Prostate Cancer: Lessons Learned from 68 Cases and Implications for Future Clinical Management.
    Linxweiler J; Sprenk J; Cascetta K; Pryalukhin A; Hölters S; Zeuschner P; Nini A; Al-Kailani Z; Ezziddin S; Bohle RM; Fries P; Ohlmann CH; Heinzelbecker J; Siemer S; Stöckle M; Junker K; Saar M
    J Urol; 2021 Jul; 206(1):88-96. PubMed ID: 33617326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.